CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells-Reference-Cited by-同舟云学术

CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells

Published:2023-11-30 Issue:1 Volume:24 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Chen Zibo¹,Liu Xi¹,Kawakami Masanori¹,Liu Xiuxia¹,Baker Allison²,Bhatawadekar Aayush²,Tyutyunyk-Massey Liliya¹,Narayan Kedar²,Dmitrovsky Ethan¹^ORCID

Affiliation:

1. Molecular Pharmacology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA

2. Center for Molecular Microscopy, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda and Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA

Funder

Frederick National Laboratory’s

Samuel Waxman Cancer Research Foundation

American Cancer Society Professorship

NCI Intramural Research Program and Center for Cancer Research, NCI

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2023.2279241

Reference58 articles.

1. Hallmarks of Cancer: The Next Generation

2. Centrosome aberrations: cause or consequence of cancer progression?

3. A mechanism linking extra centrosomes to chromosomal instability

4. Centrosome Dysfunction Contributes to Chromosome Instability, Chromoanagenesis, and Genome Reprograming in Cancer

5. Causes and consequences of centrosome abnormalities in cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents;Bioorganic Chemistry;2024-09